← All trials
NCT02009579
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2014
- Primary completion
- May 1, 2017
- Completion date
- Jul 1, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 120
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Katholieke Universiteit LeuvenLead sponsor
- Grupo Español de Investigación en Cáncer de OvarioCollaborator
- North Eastern Germany Society of Gynaecologic OncologyCollaborator
- University of LondonCollaborator
- Multicenter Italian Trials in Ovarian CancerCollaborator
- Mario Negri InstituteCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.